Experimental study on the influence of low-frequency and low-intensity ultrasound on the permeability of the Mycobacterium smegmatis cytoderm and potentiation with levofloxacin

Ultrason Sonochem. 2017 Jul:37:1-8. doi: 10.1016/j.ultsonch.2016.12.024. Epub 2016 Dec 19.

Abstract

Tuberculosis is an infectious disease caused by the bacterium M. tuberculosis. The aim of this study was to investigate the bactericidal effect and underlying mechanisms of low-frequency and low-intensity ultrasound combined with levofloxacin treatment against M. smegmatis (a surrogate of M. tuberculosis). As part of this study, M. smegmatis was continuously irradiated with low frequency ultrasound (42kHz) using several different doses whereby both intensity (0.138, 0.190 and 0.329W/cm2) and exposure time (5, 15 and 20min) were varied. Flow cytometric analyses revealed that the permeability of M. smegmatis increased following ultrasound exposure. The survival rate, structure and morphology of bacteria in the lower-dose (ISATA=0.138W/cm2 for 5min) ultrasound group displayed no significant differences upon comparison with the untreated group. However, the survival rate of bacteria was significantly reduced and the bacterial structure was damaged in the higher-dose (ISATA=0.329W/cm2 for 20min) ultrasound group. Ultrasound irradiation (0.138W/cm2) was subsequently applied to M. smegmatis in combination with levofloxacin treatment for 5min. The results demonstrated that the bactericidal effect of ultrasonic irradiation combined with levofloxacin is higher compared to ultrasound alone or levofloxacin alone.

Keywords: Bactericidal effect; Levofloxacin; Low-frequency and low-intensity ultrasound; M. smegmatis; Permeability.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Cell Wall / drug effects*
  • Cell Wall / metabolism*
  • Levofloxacin / pharmacology*
  • Mycobacterium smegmatis / cytology*
  • Mycobacterium smegmatis / drug effects*
  • Permeability / drug effects
  • Sonication*
  • Temperature

Substances

  • Anti-Bacterial Agents
  • Levofloxacin